Search

Your search keyword '"Anna Pensalfini"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Anna Pensalfini" Remove constraint Author: "Anna Pensalfini"
37 results on '"Anna Pensalfini"'

Search Results

1. Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration

2. Intracellular Injection of Brain Extracts from Alzheimer’s Disease Patients Triggers Unregulated Ca2+ Release from Intracellular Stores That Hinders Cellular Bioenergetics

3. Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques

4. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction

5. Faulty autolysosome acidification in Alzheimer’s disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques

6. Preclinical and Clinical Studies of p38α MAP kinase inhibition to Treat Basal Forebrain Cholinergic Dysfunction and Degeneration

7. Assessing Rab5 Activation in Health and Disease

8. Transgenic expression of a ratiometric autophagy probe specifically in neurons enables the interrogation of brain autophagy in vivo

9. Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease

10. Endosomal Dysfunction Induced by Directly Over-Activating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease

11. Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer’s Disease

12. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

13. Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques

14. Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates

15. Erratum

16. Atomic View of a Toxic Amyloid Small Oligomer

17. Membrane cholesterol enrichment prevents Aβ-induced oxidative stress in Alzheimer's fibroblasts

18. Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane

19. Generation of reactive oxygen species by beta amyloid fibrils and oligomers involves different intra/extracellular pathways

20. Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress

21. Differentiation Increases the Resistance of Neuronal Cells to Amyloid Toxicity

22. Seladin-1/DHCR24 protects neuroblastoma cells against Aβ toxicity by increasing membrane cholesterol content

23. Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts

24. Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease

25. Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates

26. Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia

27. Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice

28. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers

29. A causative link between the structure of aberrant protein oligomers and their toxicity

30. Soluble Fibrillar Oligomer Levels are Elevated in Alzheimer's Disease Brain and Correlate with Cognitive Dysfunction

31. A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells

32. Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer*

33. Curcumin protects cardiac cells against ischemia-reperfusion injury: effects on oxidative stress, NF-kappaB, and JNK pathways

34. Over-expression of amyloid precursor protein in HEK cells alters p53 conformational state and protects against doxorubicin

35. Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity

36. Differing molecular mechanisms appear to underlie early toxicity of prefibrillar HypF-N aggregates to different cell types

37. New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc

Catalog

Books, media, physical & digital resources